BioNTech (UK) Price on December 19, 2024
| 0A3M Stock | USD 110.25 4.06 3.55% |
Below is the normalized historical share price chart for BioNTech SE extending back to September 16, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BioNTech stands at 110.25, as last reported on the 20th of December, with the highest price reaching 114.26 and the lowest price hitting 110.25 during the day.
If you're considering investing in BioNTech Stock, it is important to understand the factors that can impact its price. As of now, BioNTech Stock is very steady. BioNTech SE secures Sharpe Ratio (or Efficiency) of 0.0025, which signifies that the company had a 0.0025% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for BioNTech SE, which you can use to evaluate the volatility of the firm. Please confirm BioNTech's Risk Adjusted Performance of 0.01, mean deviation of 2.05, and Downside Deviation of 3.08 to double-check if the risk estimate we provide is consistent with the expected return of 0.0075%.
At this time, BioNTech's Other Stockholder Equity is quite stable compared to the past year. Total Stockholder Equity is expected to rise to about 21.3 B this year, although the value of Capital Stock will most likely fall to about 259.5 M. . BioNTech Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 97.935 | 50 Day MA 113.7585 | Beta 0.2411 |
BioNTech |
Sharpe Ratio = 0.0025
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 0A3M |
Estimated Market Risk
| 3.04 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BioNTech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioNTech by adding BioNTech to a well-diversified portfolio.
Price Book 1.4002 | Enterprise Value Ebitda 110.8146 | Price Sales 3.4861 | Shares Float 86.1 M | Wall Street Target Price 219.54 |
BioNTech Valuation on December 19, 2024
It is possible to determine the worth of BioNTech on a given historical date. On December 19, 2024 BioNTech was worth 112.4 at the beginning of the trading date compared to the closed value of 110.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of BioNTech stock. Still, in general, we apply an absolute valuation method to find BioNTech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of BioNTech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against BioNTech's related companies.
| Open | High | Low | Close | Volume | |
| 116.97 | 116.97 | 114.31 | 114.31 | 2,569 | |
12/19/2024 | 112.40 | 114.26 | 110.25 | 110.25 | 15.00 |
| Backtest BioNTech | | | BioNTech History | | | BioNTech Valuation | Previous |
BioNTech Trading Date Momentum on December 19, 2024
| On December 19 2024 BioNTech SE was traded for 110.25 at the closing time. The highest price during the trading period was 114.26 and the lowest recorded bid was listed for 110.25 . The volume for the day was 15.0. This history from December 19, 2024 did not affect price variability. The overall trading delta to the current price is 1.95% . |
BioNTech SE Fundamentals Correlations and Trends
By evaluating BioNTech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among BioNTech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. BioNTech financial account trend analysis is a perfect complement when working with valuation or volatility modules.About BioNTech Stock history
BioNTech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioNTech is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioNTech SE will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioNTech stock prices may prove useful in developing a viable investing in BioNTech
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 237.7 M | 260.6 M | |
| Net Income Applicable To Common Shares | 11.8 B | 12.4 B |
BioNTech Quarterly Net Working Capital |
|
BioNTech Stock Technical Analysis
BioNTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
BioNTech Period Price Range
Low | December 20, 2024
| High |
0.00 | 0.00 |
BioNTech SE cannot be verified against its exchange. Please verify the symbol is currently traded on London IL. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
BioNTech December 20, 2024 Market Strength
Market strength indicators help investors to evaluate how BioNTech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioNTech shares will generate the highest return on investment. By undertsting and applying BioNTech stock market strength indicators, traders can identify BioNTech SE entry and exit signals to maximize returns
BioNTech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BioNTech's price direction in advance. Along with the technical and fundamental analysis of BioNTech Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioNTech to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.01 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | (0.01) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.